We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX healthcare shares finished in the red on Friday, with the S&P/ASX 200 Health Care IndexÂ...
Read ArticleS&P/ASX All Ordinaries (ASX: XAO) shares are up 0.58% to 8,606.1 points at the time of writing o...
Read ArticleUS stocks climbed overnight, with the S&P 500 reaching a new record following the release of e...
Read ArticleS&P/ASX All Ordinaries Index (ASX: XAO) share Australian Clinical Labs Ltd (ASX: ACL) is trading...
Read ArticleFund manager Crescent Capital has announced its complete exit from Australian Clinical Labs (ASX: AC...
Read ArticleIn a notable rebound, the Australian share market demonstrated resilience as it saw broad gains foll...
Read ArticleHighlights: ASX 200 futures indicate a positive opening with a rise of 50 points, driven by a s...
Read ArticleUS stocks took a sharp downturn on Tuesday as technology shares faltered and new economic data rei...
Read ArticleUS stocks took a sharp downturn on Tuesday as technology shares faltered and new economic data reign...
Read ArticleThe ASX200 closed down more than 2% at 7,943 points. Despite hitting a fresh all-time record yest...
Read ArticleMonitoring short interest can provide valuable insights into market sentiment and potential concerns...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleHighlights: ASX 200 futures fall 1.09%, mirroring losses in major US indices and mixed global...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleSome experts have revealed where they see value within the S&P/ASX 300 Index (ASX: XKO) share la...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleThe Australian share market may be trading near its record high but that hasn't stopped some ASX 300...
Read ArticleThe biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Ot...
Read ArticleThe biomedical treatment of disease and injury is what we call Pathology. Needles. Blood. Tissue. Ot...
Read ArticleUS stocks slid as mixed economic data raised fears that stagflation may rear its ugly head, as gro...
Read ArticleUS stocks slid as mixed economic data raised fears that stagflation may rear its ugly head, as growt...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which shares...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which share...
Read ArticleUS markets bounced back after three consecutive losing sessions & extended their first quarter...
Read ArticleUS markets bounced back after three consecutive losing sessions & extended their first quarter a...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which share...
Read ArticleCheaper homes and ASX small-cap shares are delivering superior capital growth to investors in 2024,...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which share...
Read ArticleAt the start of each week, I like to look at ASIC's short position report to find out which share...
Read ArticleIt has been another busy day of earnings releases on Wednesday. Some results have gone down well wi...
Read ArticleIt's fair to say that ASX healthcare shares have flummoxed investors over the past couple of years....
Read ArticleAfter two years of shocking underperformance, ASX small-cap shares made a stunning comeback towards...
Read ArticleASX healthcare share Australian Clinical Labs Ltd (ASX: ACL) has seen a large sell-off this year. S...
Read ArticleThe nation’s privacy watchdog has launched civil proceedings against Australian Clinical Labs (ASX:...
Read ArticleOne of the biggest potential reasons for massive price movement in an ASX stock is mergers and acqu...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticlePilbara Minerals has become the most shorted ASX stock as price of lithium falls from 2022 highs Fl...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleThe ASX 200 climbed on Thursday Iron ore, uranium, and coal stocks mostly rallied Australian employ...
Read ArticleThe $1.58 billion off-market takeover bid for pathology company Healius (ASX: HLS) has been put on h...
Read ArticleThe Dow Jones Industrial Average fell Wednesday as traders absorbed a hotter-than-expected August...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleThe Healius Ltd (ASX: HLS) share price finished the session on Wednesday up 7.75% after the company...
Read ArticleIt’s been a mildly pleasant day for the All Ordinaries Index (ASX: XAO) and most ASX All Ords share...
Read ArticleThe Australian Competition and Consumer Commission (ACCC) is wary of the possible market impact if t...
Read ArticleBPH Global about to ramp up China business ACL faces ACCC resistance on proposed takeover of Healiu...
Read ArticleThe Australian Competition and Consumer Commission (ACCC) has dealt a blow to ACL’s (ACL) proposed a...
Read ArticleIf youâre on the lookout for bargain buys, then you may want to check out Australian Clinical Lab...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleA bid from Australian Clinical Labs (ASX: ACL) to merge with pathology services business Healius (AS...
Read ArticleThere is an impression among many investors that big riches can only be achieved with ASX growth sh...
Read ArticleThe ASX boards are home to hundreds of shares. And many of them pay out dividends to their investor...
Read ArticleShareCafeWeaker financial sector hits markets: Google and Alphabet rise afterhours ...
Read ArticleThe Australian Ethical Investment has divested its Lendlease holding The ESG-focused fundie explain...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleThere’s a little-known ASX All Ords share currently trading on a staggering 20% gross trailing divi...
Read ArticleHealius (HLS) is dealt a blow as the Takeovers Panel decides against conducting proceedings over Aus...
Read ArticleThe conditions of a $1.58 billion bid from Australian Clinical Labs (ASX: ACL) are ‘overly restricti...
Read ArticleASX healthcare shares have underperformed the broader market since the pandemic-induced market lows...
Read ArticleHealius (HLS) reaffirms its “no action” stance to shareholders in relation to an off-market takeover...
Read ArticleThe ASX finished flattish on Monday Energy stocks lagged, while Utilities and Real Estate led There...
Read ArticleShareCafeDeutsche Bank the latest international bank to tumble Stocks rose...
Read ArticleASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer f...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a disappointing session on Thursday. In afternoon t...
Read ArticleShareCafeASX closes 1.38% lower as investors digest Credit Suisse takeover by Peter Milios On Mond...
Read ArticleAustralian Clinical Labs has put an offer to Healius to swap shares in an off-market takeover offer....
Read ArticleASX accelerated losses in the afternoon, closing over 1% lower Healthcare stock Healius gets takeov...
Read ArticleAustralian Clinical Labs (ASX: ACL) has lobbed a $1.58 billion off-market offer to merge with one of...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has started the week deep in the red. At the time of writing,...
Read ArticleHealius gets takeover offer from ALC, a company more than half its size Neurotech will launch Phase...
Read ArticleThe Healius Ltd (ASX: HLS) share price has jumped after receiving a takeover offer from Australian C...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price is having a solid start to the week. In mor...
Read ArticleThe Healius Ltd (ASX: HLS) share price is defying the market weakness and pushing higher on Monday....
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleWith much uncertainty hanging over both consumers and businesses, stock picking at the moment is a...
Read ArticleThe end of the week is drawing near, and with it comes a massive day for ASX shares and their earni...
Read ArticleShareCafe3 Small Caps Set for Long-Term Success by Simon Conn and Marc Whittaker Calendar year 202...
Read ArticleAlthough — or maybe because — small-cap ASX shares were absolutely hammered in 2022, some experts a...
Read ArticleIf you want to buy a car, you try to look for the best price. Who in their right mind would want t...
Read ArticleS&P/ASX 200 Index (ASX: XJO) healthcare shares saw a very mixed performance during the COVID-19...
Read ArticleSure, it’s been a frightening time for investors. But 2022 has also been an opportunity to pick up...
Read ArticleThe ASX is up 0.50% with Energy leading the way Energy stocks gain as coal plays led again The Euro...
Read ArticleHighlights The S&P/ASX 200 closed marginally up on Thursday (27 October 2022), gaining 41.40...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At t...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price is crashing deep into the red on Thursday....
Read ArticleAustralian Clinical Labs (ASX: ACL) owned Medlab Pathology has joined a growing list of companies im...
Read ArticleShareCafeUS markets rise as EV battery integration grows rapidly under Biden Administration ...
Read ArticleWhen investing in times of economic uncertainty like now, it can help to think of the brands you us...
Read ArticleWith ASX reporting season in full swing, S&P/ASX 200 Index (ASX: XJO) shares are declaring divi...
Read ArticleWeâre well and truly in the thick of ASX reporting season. The biggest names in the All Ordinarie...
Read ArticleShareCafeEnergy crisis playing out across the globe US equities finished lo...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is a sea of red and down heavily. At the...
Read ArticleHighlights XAO or All Ords entails the 500 largest companies on the ASX XAO is down by nearly 5...
Read ArticleIDX snaps up QLD-based radiology group for circa $38m NSB starts HREC review process Credit Suiss...
Read ArticleIn what can only be described as a remarkable turnaround, the Aussie sharemarket is closing in on br...
Read ArticleThe federal budget has, understandably, been the talk of the town today, with many market watchers...
Read ArticleHighlights Stock exchange rules determine the ex-dividend date once the corporation sets the rec...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price dropped with the market on Thursday despite...
Read ArticleAustralian Clinical Labs (ASX: ACL) has been collecting both swabs and earnings as a wave of COVID-1...
Read ArticleKey points The benchmark index has started the year well after a choppy period these past few mont...
Read ArticleThere are a few S&P/ASX 200 Index (ASX: XJO) shares that are making a lot of revenue and profit...
Read ArticleReturns in the ASX healthcare basket were fairly robust throughout 2021. Sector earnings saw a retu...
Read ArticleASX investors evidently shrugged off omicron fears in December, with the last month of the 2021 bein...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price is tumbling today, but it’s had a whopping...
Read ArticleIt has been another busy week for Australia’s top brokers. This has led to the release of a large n...
Read ArticleWall Street rallies as sentiment lifts US and European stock markets finally rose overnight after th...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At t...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price is up more than 5% today to $5.26 after the...
Read ArticleThe arrival of omicron in Australia has led to COVID test volumes spiking again and Australian Clini...
Read Article21 Dec 2021 - A snapshot of the stocks on the move featuring AMP (ASX:AMP), Magellan Financial (ASX:...
Read Article21 Dec 2021 - Australian Clinical Labs (ASX:ACL) has upgraded its earnings and revenue forecast for...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price has hit a record high on Tuesday morning. A...
Read ArticleWall Street falls amid Omicron uncertainty The US stock markets fell for the third consecutive day,...
Read ArticleAustralian Clinical Labs (ACL) acquires Medlab Pathology, who own laboratories and collection centr...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) looks set to start the week with a decline...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.92% at the time of writing, compared to the br...
Read ArticleIf you’re interested in adding some small caps to your portfolio, then you may want to check out th...
Read ArticleThe PolyNovo Ltd (ASX: PNV) share price has been under pressure in recent weeks. Since the beginnin...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 1.5% at the time of writing, compared to the broader index w...
Read ArticleAustralian Clinical Labs (ASX: ACL) is set to nearly double its number of collection centres in NSW...
Read ArticleThe healthcare sector is home to a number of companies with the potential to grow strongly in the f...
Read ArticleWhether the market is up or down, there is one type of ASX stock that investors love — businesses t...
Read ArticleThe healthcare sector is having a tough week and has fallen heavily. For example, the S&P/ASX 2...
Read ArticleThe ASX 200 health stocks index (XHJ) is falling sharply by 2.40% at the time of writing, compared t...
Read ArticleThe COVID-19 outbreaks in NSW and Victoria have led to a surge in demand for testing, and that trend...
Read ArticleWall Street mixed as US Fed sends warning on inflation US stock markets finished in mixed territorie...
Read ArticleThe WAM Capital Limited (ASX: WAM) share price has risen by 6% over the last month. What may be nex...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price has leapt into the green on Thursday as the...
Read ArticleTop performers from today’s list companies releasing annual results included Swoop (ASX:SWP), Austra...
Read ArticleThe ASX 200 health stocks index (XHJ) fell by 1.55% this morning, compared to the broader index whic...
Read ArticleThe fund manager Wilson Asset Management (WAM) has told investors about two ASX shares that it has...
Read ArticleLeading fund manager Wilson Asset Management (WAM) has revealed two ASX shares that it rates as buy...
Read ArticleThe cavalcade of life science initial public offers (IPOs) and ASX listings shows few signs of reced...
Read ArticleAn ASX share that only listed a few weeks ago is being ignored by investors, even though next month...
Read ArticleThe COVID-19 lockdowns of our two biggest cities have prompted brokers to upgrade their earnings ca...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticlePoint of care diagnostic test provider Lumos Diagnostics (ASX:LDX) is set to list on the ASX on July...
Read ArticleThe first major test for a newly listed ASX stocks is if it can meet or exceed its prospectus foreca...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price is pushing higher on Monday. In afternoon t...
Read ArticleThe Australian Clinical Labs Ltd (ASX: ACL) share price climbed to a new high of $3.88 during tradin...
Read ArticleSummary The S&P/ASX 200 scaled a new high on Thursday, ending 0.6% up at 7260.1. The index...
Read ArticleA big surge in energy shares led the ASX into positive territory for the second day in a row. The AS...
Read ArticleShareCafeAPH Helping Humans, and Pets, Through Hemp One of the more intriguing aspects of the sto...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleThere are many reasons why a company might change its name, from being taken over to hiding a shady...
Read ArticleOnce biotechnology company Alchemia has acquired hemp grower Australian Primary Hemp (ASX: APH) as p...
Read ArticleImugene Limited (ASX: IMU), an Australian-headquartered clinical-stage immuno-oncology company, focu...
Read ArticleThe ASX’s 32 tradeable pot stocks and pot stock wannabees are down 17 per cent over the last 12 mont...
Read ArticleVigilance and self-awareness on the performance of stocks is perhaps the most effective catalyst tha...
Read ArticleIt has been a few lean years at Alchemia (ASX: ACL). In October 2014 the Phase III trial of an anti-...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
